SEC 13F Intelligence

Natixis Advisors, LLC / ABBV

Natixis Advisors, LLC’s Abbvie Inc Position

Does Natixis Advisors, LLC own Abbvie Inc (ABBV)? Yes — 1.31M shares worth $286M (+0.40% of its 13F portfolio) as of Q1 2026, up from 1.30M shares the prior filed quarter.

Position Value
$286M
Q1 2026
Shares
1.31M
% of Portfolio
+0.40%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $39MQ4 ’18Q1 ’19: $35MQ2 ’19: $42MQ3 ’19: $51MQ4 ’19: $62MQ4 ’19Q1 ’20: $43MQ2 ’20: $61MQ3 ’20: $40MQ4 ’20: $41MQ4 ’20Q1 ’21: $46MQ2 ’21: $53MQ3 ’21: $50MQ4 ’21: $71MQ4 ’21Q1 ’22: $98MQ2 ’22: $88MQ3 ’22: $89MQ4 ’22: $110MQ4 ’22Q1 ’23: $117MQ2 ’23: $85MQ3 ’23: $135MQ4 ’23: $154MQ4 ’23Q1 ’24: $198MQ2 ’24: $198MQ3 ’24: $240MQ4 ’24: $213MQ4 ’24Q1 ’25: $270MQ2 ’25: $242MQ3 ’25: $300MQ4 ’25: $298MQ4 ’25Q1 ’26: $286Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.31M$286M+0.40%
Q4 20251.30M$298M+0.42%
Q3 20251.30M$300M+0.44%
Q2 20251.30M$242M+0.38%
Q1 20251.29M$270M+0.50%
Q4 20241.20M$213M+0.40%
Q3 20241.21M$240M+0.47%
Q2 20241.15M$198M+0.43%
Q1 20241.09M$198M+0.46%
Q4 2023996.4K$154M+0.41%
Q3 2023904.9K$135M+0.41%
Q2 2023631.6K$85M+0.26%
Q1 2023736.8K$117M+0.40%
Q4 2022678.7K$110M+0.41%
Q3 2022664.6K$89M+0.38%
Q2 2022576.2K$88M+0.39%
Q1 2022601.7K$98M+0.37%
Q4 2021527.1K$71M+0.27%
Q3 2021465.1K$50M+0.21%
Q2 2021471.7K$53M+0.25%
Q1 2021424.1K$46M+0.24%
Q4 2020381.8K$41M+0.24%
Q3 2020454.3K$40M+0.25%
Q2 2020618.2K$61M+0.40%
Q1 2020563.2K$43M+0.35%
Q4 2019702.7K$62M+0.44%
Q3 2019672.3K$51M+0.40%
Q2 2019573.4K$42M+0.34%
Q1 2019430.7K$35M+0.30%
Q4 2018426.3K$39M+0.39%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Natixis Advisors, LLC’s full portfolio or all institutional holders of ABBV.